On this page:

 Chimeric Antigen Receptor T- Cell Therapy (CAR-T) is a treatment pathway currently for patients with certain types of blood cancer. 

It is a treatment that consists of taking a certain type of immune system cell, which is then modified and given back to the patient. The aim is to use the body’s immune system to treat their disease. 

For more information and detail on CAR-T Therapy please click on the following links: 

HAE_CART.pdf 

CAR-T cell therapy | Lymphoma Action 

CAR T-cell therapy – Leukaemia Care 

What is CAR T-cell therapy? | Anthony Nolan